Publicacións nas que colabora con Álvaro Arjona Sánchez (7)

2023

  1. Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study

    Cancers, Vol. 15, Núm. 17

  2. Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

    Clinical and Translational Oncology, Vol. 25, Núm. 12, pp. 3378-3394

2022

  1. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

    BMC Cancer, Vol. 22, Núm. 1

2020

  1. Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

    World Journal of Surgical Oncology, Vol. 18, Núm. 1

  2. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)

    Clinical and Translational Oncology, Vol. 22, Núm. 1, pp. 130-136

2019

  1. RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score

    Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2595-2604

2018

  1. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey

    European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236